Incannex wins approval of overseas findings, secures A$5.1 million R&D tax refund

Reuters2026/08/11 11:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Incannex received A$ 5.1 million from Australia’s R&D Tax Incentive Program following approval of overseas findings for FY25.
Total 2026 proceeds under the program reached more than A$ 11.2 million in non-dilutive funding.
Cash inflow supports clinical development programs, including IHL-42X and PSX-001.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incannex Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-087493), on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Incannex wins approval of overseas findings, secures A$5.1 million R&D tax refund

You may also like

Crypto prices